Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Simon

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
Genome Research|January 11, 2007
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcerTimothy P Stinear, Torsten Seemann, Sacha Pidot, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitisIoanna Minopoulou, Artur Wilhelm, Fredrik Albach, et al.
Frontiers in Pediatrics|February 3, 2022
Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters)Anne B Chang, Maree Toombs, Mark D Chatfield, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2012
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectionNorah A Terrault, Michelle E Roland, Thomas Schiano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 24, 2021
Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated CohortDavid Simon, Koray Tascilar, Arnd Kleyer, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
The Lancet. Rheumatology|February 1, 2024
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Tascilar, Melanie Hagen, Arnd Kleyer, et al.
Nature Communications|July 26, 2020
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversionDavid Simon, Koray Tascilar, Gerhard Krönke, et al.
Annals of the Rheumatic Diseases|October 23, 2025
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase SyndromeElpida Phithak, Fredrik N Albach, Ioanna Minopoulou, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Genome Research|January 11, 2007
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcerTimothy P Stinear, Torsten Seemann, Sacha Pidot, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitisIoanna Minopoulou, Artur Wilhelm, Fredrik Albach, et al.
Frontiers in Pediatrics|February 3, 2022
Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters)Anne B Chang, Maree Toombs, Mark D Chatfield, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2012
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectionNorah A Terrault, Michelle E Roland, Thomas Schiano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 24, 2021
Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated CohortDavid Simon, Koray Tascilar, Arnd Kleyer, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
The Lancet. Rheumatology|February 1, 2024
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Tascilar, Melanie Hagen, Arnd Kleyer, et al.
Nature Communications|July 26, 2020
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversionDavid Simon, Koray Tascilar, Gerhard Krönke, et al.
Annals of the Rheumatic Diseases|October 23, 2025
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase SyndromeElpida Phithak, Fredrik N Albach, Ioanna Minopoulou, et al.
Pageof 26